Across TCGA pan-cancer cohorts, MTCYBP4 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MTCYBP4’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MTCYBP4 RNA is repressed in tumor relative to normal tissue. In most cancer types MTCYBP4 is over-expressed in tumor, although a few such as KIRC and STAD show the opposite, repressed pattern.

KIRC and STAD are the cancer types where MTCYBP4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTCYBP4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	−0.147	.007	3	view →
STAD	All	II,III,IV	−0.305	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MTCYBP4 RNA expression & survival · all MTCYBP4 data types